ATE325805T1 - Herstellung von kristalliner dihydratform von azithromycin - Google Patents

Herstellung von kristalliner dihydratform von azithromycin

Info

Publication number
ATE325805T1
ATE325805T1 AT01204550T AT01204550T ATE325805T1 AT E325805 T1 ATE325805 T1 AT E325805T1 AT 01204550 T AT01204550 T AT 01204550T AT 01204550 T AT01204550 T AT 01204550T AT E325805 T1 ATE325805 T1 AT E325805T1
Authority
AT
Austria
Prior art keywords
preparation
azithromycin
dihydrate form
crystalline dihydrate
crystalline
Prior art date
Application number
AT01204550T
Other languages
German (de)
English (en)
Inventor
Jasanada Miguel Santos Bayod
Garcia Isidro Llorente
Mari Felix Fernandez
Original Assignee
Astur Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astur Pharma Sa filed Critical Astur Pharma Sa
Application granted granted Critical
Publication of ATE325805T1 publication Critical patent/ATE325805T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT01204550T 1999-11-26 2000-02-23 Herstellung von kristalliner dihydratform von azithromycin ATE325805T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES009902620A ES2177373B1 (es) 1999-11-26 1999-11-26 Preparacion de azitromicina en su forma no cristalina

Publications (1)

Publication Number Publication Date
ATE325805T1 true ATE325805T1 (de) 2006-06-15

Family

ID=8310747

Family Applications (2)

Application Number Title Priority Date Filing Date
AT01204550T ATE325805T1 (de) 1999-11-26 2000-02-23 Herstellung von kristalliner dihydratform von azithromycin
AT00500028T ATE243704T1 (de) 1999-11-26 2000-02-23 Herstellung von nicht-kristallinen und kristallinen dihydratformen von azithromycin

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT00500028T ATE243704T1 (de) 1999-11-26 2000-02-23 Herstellung von nicht-kristallinen und kristallinen dihydratformen von azithromycin

Country Status (9)

Country Link
US (1) US6451990B1 (https=)
EP (2) EP1103558B1 (https=)
JP (2) JP4260354B2 (https=)
AT (2) ATE325805T1 (https=)
CA (1) CA2326930C (https=)
DE (2) DE60003509T2 (https=)
ES (2) ES2177373B1 (https=)
PL (1) PL195910B1 (https=)
TR (1) TR200003474A3 (https=)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP20020231A2 (en) * 2002-03-18 2003-12-31 Pliva D D ISOSTRUCTURAL PSEUDOPOLYMORPHS OF 9-DEOXO-9a-AZA-9a-METHYL-9a-HOMOERYTHROMYCIN A
CA2245398C (en) 1998-08-21 2002-01-29 Apotex Inc. Azithromycin monohydrate isopropanol clathrate and methods for the manufacture thereof
ES2162764B1 (es) * 2000-05-17 2003-04-01 Ercros Ind Sa Forma polimorfica del dihidrato de azitromicina, y su procedimiento deobtencion.
HRP20030430B1 (hr) * 2000-11-27 2011-11-30 Biochemie S.A. Makrolidni solvati
IN190080B (https=) * 2001-01-29 2003-06-07 Alembic Ltd
KR100491183B1 (ko) * 2001-03-21 2005-05-25 한미약품 주식회사 아지트로마이신의 제조방법 및 이 방법에 사용되는9-데옥소-9에이-아자-9에이-호모에리트로마이신 에이의결정성 수화물
SI1390377T1 (sl) * 2001-05-22 2006-06-30 Pfizer Prod Inc Nova kristalna oblika azitromicina
ES2258142T3 (es) 2001-05-22 2006-08-16 Pfizer Products Inc. Nueva forma cristalina.
US6861413B2 (en) 2001-05-22 2005-03-01 Pfizer Inc. Stable non-dihydrate azithromycin oral suspensions
PL371259A1 (pl) 2001-12-21 2005-06-13 Pfizer Products Inc. Bezpośrednio sprasowywalne preparaty azytromycyny
MXPA04007847A (es) 2002-02-13 2005-02-24 Biogal Gyogyszergyar Metodo para extraer un macrolido de biomateria.
US7452692B2 (en) 2002-02-13 2008-11-18 Teva Gyógyszergyár Zártkörüen Müködö Részvénytársaság Method for extracting a macrolide from biomatter
HRP20020614A2 (en) 2002-07-22 2004-06-30 PLIVA-ISTRAŽIVAČKI INSTITUT d.o.o. Rhombic pseudopolymorph of 9-deoxo-9a-aza-9a-methyl-9a-homoerythromycin a
WO2004089958A2 (en) * 2003-03-31 2004-10-21 TEVA Gyógyszergyár Részvénytársaság Crystallization and purification of macrolides
PL1558622T3 (pl) 2003-07-24 2008-06-30 Teva Gyogyszergyar Zartkoerueen Muekoedoe Reszvenytarsasag Sposób oczyszczania makrolidów
KR100844628B1 (ko) * 2003-12-04 2008-07-07 화이자 프로덕츠 인크. 제약상 다입자의 제조 방법
US7384921B2 (en) * 2004-02-20 2008-06-10 Enanta Pharmaceuticals, Inc. Polymorphic forms of 6-11 bicyclic ketolide derivatives
US7468428B2 (en) 2004-03-17 2008-12-23 App Pharmaceuticals, Llc Lyophilized azithromycin formulation
US20060116336A1 (en) * 2004-03-17 2006-06-01 American Pharmaceutical Partners, Inc. Lyophilized azithromycin formulation
WO2006115494A1 (en) * 2005-04-26 2006-11-02 American Pharmaceutical Partners, Inc. Lyophilized azithromycin formulation
US7683162B2 (en) 2004-08-30 2010-03-23 Taro Pharmaceutical Industries Limited Process of preparing a crystalline azithromycin monohydrate
US7464012B2 (en) * 2004-12-10 2008-12-09 L'air Liquide, Societe Anonyme A Directoire Et Conseil De Surveillance Pour L'etude Et L'exploitation Des Procedes Georges Claude Simplified process simulator
US7582312B2 (en) * 2004-11-15 2009-09-01 Discovery Laboratories, Inc. Methods to produce lung surfactant formulations via lyophilization and formulations and uses thereof
CA2584430A1 (en) 2004-12-01 2006-06-08 Teva Gyogyszergyar Zartkoruen Mukodo Reszvenytarsasag Methods for preparing pimecrolimus
JP2009501206A (ja) * 2005-07-14 2009-01-15 ファイザー・プロダクツ・インク 非晶質アジスロマイシン粒子の生成方法
WO2007067566A2 (en) * 2005-12-07 2007-06-14 Wyeth Methods for preparing crystalline rapamycin and for measuring crystallinity of rapamycin compounds using differential scanning calorimetry
UA102128C2 (en) * 2008-12-05 2013-06-10 Х. Луннбек А/С Nalmefene hydrochloride dihydrate
WO2011015219A1 (en) 2009-08-06 2011-02-10 Shifa Pharmed Industrial Group Co. Process for the purification of azithromycin by separation from its thermal degradation products and/or isomers
CA2784494C (en) * 2009-12-18 2019-03-12 North-West University Composition comprising an amorphous non-crystalline glass form of roxithromycin
WO2013088274A1 (en) * 2011-12-14 2013-06-20 Wockhardt Limited Anhydrous amorphous azithromycin composition free of azithromycin dihydrate
CN106188177A (zh) * 2016-07-12 2016-12-07 浙江亚太药业股份有限公司 一种阿奇霉素化合物的制备方法及其药物制剂
CN108003109A (zh) * 2017-12-18 2018-05-08 南开大学 一种大环内酯化合物的晶型及其制备方法与用途

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI8110592A8 (en) * 1981-03-06 1996-06-30 Pliva Pharm & Chem Works Process for preparing of n-methyl-11-aza-10-deoxo-10-dihydroerythromycine a and derivatives thereof
US4474768A (en) 1982-07-19 1984-10-02 Pfizer Inc. N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates therefor
WO1989000576A1 (en) * 1987-07-09 1989-01-26 Pfizer Inc. Azithromycin dihydrate
US5686587A (en) 1993-05-19 1997-11-11 Pfizer Inc. Intermediate for azithromycin
ECSP951389A (es) 1995-02-21 1996-05-10 Un procedimiento de obtencion de hidrato de azitromicina
ES2122905B1 (es) 1996-07-11 1999-11-16 Astur Pharma Sa Sintesis de 11,12-hidrogenoortoborato de 9-desoxo-9a-aza-11,12-desoxi-9a-metil-9a-homoeritromicina a. un procedimiento para la preparacion de 9-desoxo-9a-aza-9a-metil-9a-homoeritromicina a dihidrato (azitromicina dihidrato).
PT102130A (pt) 1998-03-13 1999-09-30 Hovione Sociedade Quimica S A Processo de preparacao de dihidrato de azitromicina
TW546302B (en) * 1998-05-08 2003-08-11 Biochemie Sa Improvements in macrolide production
CA2245398C (en) * 1998-08-21 2002-01-29 Apotex Inc. Azithromycin monohydrate isopropanol clathrate and methods for the manufacture thereof

Also Published As

Publication number Publication date
ATE243704T1 (de) 2003-07-15
EP1103558A3 (en) 2001-07-04
EP1234833A3 (en) 2003-03-12
PL344101A1 (en) 2001-06-04
JP4260354B2 (ja) 2009-04-30
JP2009007376A (ja) 2009-01-15
DE60003509D1 (de) 2003-07-31
EP1103558A2 (en) 2001-05-30
EP1234833B1 (en) 2006-05-10
ES2177373A1 (es) 2002-12-01
US6451990B1 (en) 2002-09-17
PL195910B1 (pl) 2007-11-30
TR200003474A2 (tr) 2001-07-23
TR200003474A3 (tr) 2001-07-23
ES2207403B1 (es) 2005-03-01
EP1103558B1 (en) 2003-06-25
DE60027919D1 (de) 2006-06-14
JP2001187797A (ja) 2001-07-10
ES2177373B1 (es) 2003-11-01
DE60003509T2 (de) 2004-04-15
EP1234833A2 (en) 2002-08-28
ES2207403A1 (es) 2004-05-16
CA2326930A1 (en) 2001-05-26
CA2326930C (en) 2005-03-22

Similar Documents

Publication Publication Date Title
ATE325805T1 (de) Herstellung von kristalliner dihydratform von azithromycin
ZA926813B (en) Imidazolidyl macrolides
GB2210879B (en) 4h-1-benzopyran-4-one derivative or its salt, process for producing the same and pharmaceutical composition comprising the same as active ingredient
NZ238340A (en) Preparation of 3-(methylamino)-piperidine derivatives
ES2193241T3 (es) Nuevas n-2-oxo2.3.4.5-tetrajodrp-1h-1,5-benzodiazepin-3-il)-3-amidas.
PT1122245E (pt) 2-amino-benzoxazinonas para o tratamento de infeccoes virais
KR950017992A (ko) 알프조신 염산염의 2수화물
LV5268A3 (lv) pristinamicina atvasinajumu iegusanas panemiens
FI952420A0 (fi) Glukopyranosidibentsotiofeenit
AU6989487A (en) Phenylimidazolecarboxylic acid amides, their preparation and their use as growth regulators
DK0873346T3 (da) Ny krystallinsk form af morfin-6-glucuronid
CY1110062T1 (el) Πολυμορφικη μορφη β της 3-(κυκλοπροπυλμεθοξυ)4- [ -4-(μεθυλσουλφονυλ)φαινυλ]-5,5-διμεθυλ-5η-φουραν-2-ονης
DK0779895T3 (da) Forbedret fremgangsmåde til fremstilling af sidekædederivater af cyclohexapeptidyl-lipopeptider
CA2485433A1 (en) Preparation of non-crystalline and crystalline dihydrate forms of azithromycin
PT828749E (pt) Composicoes e metodos para a sintese de derivados de organofosforo
PT1462439E (pt) Novos cristais estáveis de derivado do ácido fenilpropiónico substituído e processo para a sua produção
SE8601344D0 (sv) Derivat av 11-desoxi-17alfa-hydroxikortikosteron derivat av 11-desoxi-17alfa-hydroxikortikosteron
Amatuni et al. Diamond synthesis possibility investigation using CO {sub 2} laser radiation; Issledovanie vozmozhnosti sinteza almaza s ispolzovaniem izlucheniya CO {sub 2} lazera
Amatuni et al. Diamond synthesis possibility investigation using CO2 laser radiation
FR2670211B1 (fr) Procede de preparation de derives de l'acide dihydroxy-3,5 oxo-6 hexanouique.
ES2062062T3 (es) Procedimiento para la preparacion de eteres de la 2-amino-7-hidroxitetralina.
ES2156327T3 (es) Obtencion de un epoxido.
IT1273590B (it) Composti lattonici utili per il trattamento dell'osteoporosi
IT1276893B1 (it) 1,3,2-benzoossiazafosfolidine sostituite e procedimento per la loro preparazione
IT1276892B1 (it) 1,3,2-benzoossiazafosfolidine sostituite e procedimento per la loro preparazione

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties